Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'REUPTAKE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 314 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pellegrino, TC; Dunn, KL; Bayer, BM
      Mechanisms of cocaine-induced decreases in immune cell function

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Coleiro, B; Marshall, SE; Denton, CP; Howell, K; Blann, A; Welsh, KI; Black, CM
      Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine

      RHEUMATOLOGY
    3. Buchsbaum, MS; Hollander, E; Haznedar, MM; Tang, C; Spiegel-Cohen, J; Wei, TC; Solimando, A; Buchsbaum, BR; Robins, D; Bienstock, C; Cartwright, C; Mosovich, S
      Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    4. Rouillon, F
      Depression comorbid with anxiety or medical illness: The role of paroxetine

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    5. Hamilton, SP; Slager, SL; Helleby, L; Heiman, GA; Klein, DF; Hodge, SE; Weissman, MM; Fyer, AJ; Knowles, JA
      No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder

      MOLECULAR PSYCHIATRY
    6. Lynch, ME
      Antidepressants as analgesics: a review of randomized controlled trials

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    7. Ungvari, Z; Koller, A
      Mediation of EDHF-induced reduction of smooth muscle [Ca2+](i) and arteriolar dilation by K+ channels, 5,6-EET, and gap junctions

      MICROCIRCULATION
    8. Pollak, PT; Mukherjee, SD; Fraser, AD
      Sertraline-induced hypoglycemia

      ANNALS OF PHARMACOTHERAPY
    9. Smith, DF; Bender, D; Marthi, K; Cumming, P; Hansen, SB; Peters, D; Nielsen, EO; Scheel-Kruger, J; Gjedde, A
      Synthesis and evaluation of racemic [C-11]NS2456 and its enantiomers as selective serotonin reuptake radiotracers for PET

      NUCLEAR MEDICINE AND BIOLOGY
    10. Yamato, H; Kannari, K; Shen, H; Suda, T; Matsunaga, M
      Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum?

      NEUROREPORT
    11. Becker, PM; Corrigan, MH; Kasper, S; Lin, SC; Montplaisir, J; Szegedi, A; Willner, P
      Clinical efficacy of pramipexole in the treatment of conditions other thanParkinson's disease

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    12. Kasper, S; Resinger, E
      Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    13. Mello, NK; Negus, SS
      Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys

      NEUROPSYCHOPHARMACOLOGY
    14. Ho, HP; Olsson, M; Westberg, L; Melke, J; Eriksson, E
      The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: An animal model of premenstrual irritability?

      NEUROPSYCHOPHARMACOLOGY
    15. Mundo, E; Rouillon, F; Figuera, ML; Stigler, M
      Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    16. Jacobs, ES; Dickstein, DP; Liebelt, EL
      Novel psychotropic medications in children: New toxicities to master

      PEDIATRIC EMERGENCY CARE
    17. Schreiber, S; Vinokur, S; Shavelzon, V; Pick, CG; Zahavi, E; Shir, Y
      A randomized trial of fluoxetine versus amitriptyline in musculo-skeletal pain

      ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES
    18. Shores, MM; Pascualy, M; Lewis, NL; Flatness, D; Veith, RC
      Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects

      PSYCHONEUROENDOCRINOLOGY
    19. Yamada, M; Yamada, M; Yamazaki, S; Takahashi, K; Nara, K; Ozawa, H; Yamada, S; Kiuchi, Y; Oguchi, K; Kamijima, K; Higuchi, T; Momose, K
      Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex

      NEUROSCIENCE LETTERS
    20. Bayas, A; Kornhuber, J; Naumann, M
      Atypical neuroleptics and new antidepressants in the treatment of neurological disorders

      AKTUELLE NEUROLOGIE
    21. Blakely, RD
      Physiological genomics of antidepressant targets: Keeping the periphery inmind

      JOURNAL OF NEUROSCIENCE
    22. Nathan, PJ
      Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor?A review of the recent advances in its pharmacology

      JOURNAL OF PSYCHOPHARMACOLOGY
    23. Martinez, J; Perez, S; Oficialdegui, AM; Heras, B; Orus, L; Villanueva, H; Palop, JA; Roca, J; Mourelle, M; Bosch, A; Del Castillo, JC; Lasheras, B; Tordera, R; del Rio, J; Monge, A
      New 3-[4-(aryl)piperazin-1-yl]-1(benzo[b]thiophen3-yl) propane derivativeswith dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    24. Ogawa, K; Sasaki, H; Kishi, Y; Yamasaki, H; Okamoto, K; Yamamoto, N; Hanabusa, T; Nakao, T; Nishi, M; Nanjo, K
      A suspected case of proximal diabetic neuropathy predominantly presenting with scapulohumeral muscle weakness and deep aching pain

      DIABETES RESEARCH AND CLINICAL PRACTICE
    25. Pezzella, G; Moslinger-Gehmayr, R; Contu, A
      Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

      BREAST CANCER RESEARCH AND TREATMENT
    26. Asnis, GM; Hameedi, FA; Goddard, AW; Potkin, SG; Black, D; Jameel, M; Desagani, K; Woods, SW
      Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

      PSYCHIATRY RESEARCH
    27. Manier, DH; Shelton, RC; Sulser, F
      Cross-talk between PKA and PKC in human fibroblasts: what are the pharmacotherapeutic implications?

      JOURNAL OF AFFECTIVE DISORDERS
    28. Greil, W; Horvath, A; Sassim, N; Erazo, N; Grohmann, R
      Disinhibition of libido: an adverse effect of SSRI?

      JOURNAL OF AFFECTIVE DISORDERS
    29. Keller, M
      Role of serotonin and noradrenaline in social dysfunction: a review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS)

      GENERAL HOSPITAL PSYCHIATRY
    30. Ungvari, Z; Koller, A
      Homocysteine reduces smooth muscle [Ca2+](i) and constrictor responses of isolated arterioles

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    31. Hedou, G; Pryce, C; Di Iorio, L; Heidbreder, CA; Feldon, J
      An automated analysis of rat behavior in the forced swim test

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    32. Eguchi, J; Inomata, Y; Saito, K
      The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    33. D'Souza, DL; Levasseur, LM; Nezamis, J; Robbins, DK; Simms, L; Koch, KM
      Effect of alosetron on the pharmacokinetics of alprazolam

      JOURNAL OF CLINICAL PHARMACOLOGY
    34. Venkatakrishnan, K; von Moltke, LL; Greenblatt, DJ
      Human drug metabolism and the cytochromes P450: Application and relevance of in vitro models

      JOURNAL OF CLINICAL PHARMACOLOGY
    35. Cherstniakova, SA; Bi, DQ; Fuller, DR; Mojsiak, JZ; Collins, JM; Cantilena, LR
      Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) piperazine, by human cytochrome P450 enzymes

      DRUG METABOLISM AND DISPOSITION
    36. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
      Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    37. Wikell, C; Hjorth, S; Apelqvist, G; Kullingsjo, J; Lundmark, J; Bergqvist, PBF; Bengtsson, F
      Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    38. Stenfors, C; Yu, H; Ross, SB
      Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    39. Lu, L; Su, WJ; Yue, W; Ge, X; Su, F; Pei, G; Ma, L
      Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor

      LIFE SCIENCES
    40. Knobelman, DA; Hen, R; Blendy, JA; Lucki, I
      Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    41. Millan, MJ; Gobert, A; Lejeune, F; Newman-Tancredi, A; Rivet, JM; Auclair, A; Peglion, JL
      S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    42. Millan, MJ; Dekeyne, A; Papp, M; La Rochelle, CD; Macsweeny, C; Peglion, JL; Brocco, M
      S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    43. Malagie, I; Trillat, AC; Bourin, M; Jacquot, C; Hen, R; Gardier, AM
      5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex

      JOURNAL OF NEUROCHEMISTRY
    44. Martinez-Esparza, J; Oficialdegui, AM; Perez-Silanes, S; Heras, B; Orus, L; Palop, JA; Lasheras, B; Roca, J; Mourelle, H; Bosch, A; Del Castillo, JC; Tordera, R; Del Rio, J; Monge, A
      New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants

      JOURNAL OF MEDICINAL CHEMISTRY
    45. Li, XB; Inoue, T; Hashimoto, S; Koyama, T
      Effect of chronic administration of flesinoxan and fluvoxamine on freezingbehavior induced by conditioned fear

      EUROPEAN JOURNAL OF PHARMACOLOGY
    46. Treit, D; Degroot, A; Kashluba, S; Bartoszyk, GD
      Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test

      EUROPEAN JOURNAL OF PHARMACOLOGY
    47. Eltayb, A; Svensson, TH; Ahlenius, S
      Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

      EUROPEAN JOURNAL OF PHARMACOLOGY
    48. Angulo, J; Peiro, C; Sanchez-Ferrer, CF; Gabancho, S; Cuevas, P; Gupta, S; de Tejada, IS
      Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue

      BRITISH JOURNAL OF PHARMACOLOGY
    49. Pariante, CM; Makoff, A; Lovestone, S; Feroli, S; Heyden, A; Miller, AH; Kerwin, RW
      Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

      BRITISH JOURNAL OF PHARMACOLOGY
    50. Singh, VP; Jain, NK; Kulkarni, SK
      On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor

      BRAIN RESEARCH
    51. He, M; Sibille, E; Benjamin, D; Toth, M; Shippenberg, T
      Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis

      BRAIN RESEARCH
    52. Huber, R; Panksepp, JB; Yue, Z; Delago, A; Moore, P
      Dynamic interactions of behavior and amine neurochemistry in acquisition and maintenance of social rank in crayfish

      BRAIN BEHAVIOR AND EVOLUTION
    53. Dujovne, CA; Zavoral, JH; Rowe, E; Mendel, CM
      Effects of sibutramine on body weight and serum lipids: A double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia

      AMERICAN HEART JOURNAL
    54. Stein, DJ; Stein, MB; Goodwin, W; Kumar, R; Hunter, B
      The selective serotonin reuptake in more generalized and in less inhibitorparoxetine is effective generalized social anxiety disorder

      PSYCHOPHARMACOLOGY
    55. Dekeyne, A; Gobert, A; Iob, L; Cistarelli, L; Melon, C; Millan, MJ
      Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats

      PSYCHOPHARMACOLOGY
    56. Siepmann, M; Muck-Weymann, M; Joraschky, P; Kirch, W
      The effects of reboxetine on autonomic and cognitive functions in healthy volunteers

      PSYCHOPHARMACOLOGY
    57. Oerther, S; Ahlenius, S
      Involvement of 5-HT1A and 5-HT1B receptors for citalopram-induced hypothermia in the rat

      PSYCHOPHARMACOLOGY
    58. Hertel, P; Lindblom, N; Nomikos, GG; Svensson, TH
      Receptor-mediated regulation of serotonin output in the rat dorsal raphe nucleus: effects of risperidone

      PSYCHOPHARMACOLOGY
    59. Hennig, J; Lange, N; Haag, A; Rohrmann, S; Netter, P
      Reboxetine in a neuroendocrine challenge paradigm: evidence for high cortisol responses in healthy volunteers scoring high on subclinical depression

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    60. Bezchlibnyk-Butler, K; Aleksic, I; Kennedy, SH
      Citalopram - a review of pharmacological and clinical effects

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    61. Davidson, JRT
      Social anxiety disorder under scrutiny

      DEPRESSION AND ANXIETY
    62. Shelton, RC
      Intracellular mechanisms of antidepressant drug action

      HARVARD REVIEW OF PSYCHIATRY
    63. Ansari, A
      The efficacy of newer antidepressants in the treatment of chronic pain: A review of current literature

      HARVARD REVIEW OF PSYCHIATRY
    64. Cotreau, MM; von Moltke, LL; Beinfeld, MC; Greenblatt, DJ
      Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    65. Millan, MJ; Gobert, A; Rivet, JM; Adhumeau-Auclair, A; Cussac, D; Newman-Tancredi, A; Dekeyne, A; Nicolas, JP; Lejeune, F
      Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram

      EUROPEAN JOURNAL OF NEUROSCIENCE
    66. Poggesi, I; Pellizzoni, C; Fleishaker, JC
      Pharmacokinetics of reboxetine in elderly patients with depressive disorders

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    67. Jensen, JB; Mikkelsen, JD; Mork, A
      Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 inthe rat hippocampus following antidepressant treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    68. Wellman, PJ
      Norepinephrine and the control of food intake

      NUTRITION
    69. Beique, JC; Blier, P; de Montigny, C; Debonnel, G
      Potentiation by (-)pindolol of the activation of postsynaptic 5-HT1A receptors induced by venlafaxine

      NEUROPSYCHOPHARMACOLOGY
    70. Martin-Fardon, R; Weiss, F
      N-[1-(2-benzo[b]thiophenyl)cyclohexyl]piperidine (BTCP) exerts cocaine-like actions on drug-maintained responding in rats

      NEUROPSYCHOPHARMACOLOGY
    71. Hinze-Selch, D; Schuld, A; Kraus, T; Kuhn, M; Uhr, M; Haack, M; Pollmacher, T
      Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine

      NEUROPSYCHOPHARMACOLOGY
    72. Taber, MT; Kinney, GG; Pieschl, RL; Yocca, FD; Gribkoff, VK
      Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: Sensitivity to sequence of injections

      SYNAPSE
    73. Joubert, AF; Sanchez, C; Larsen, F
      Citalopram

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    74. Catalano, MC; Catalano, G; Kanfer, SN; Toner, LC; Stock, SL; Taylor, WD
      The effect of sertraline on routine blood chemistry values

      CLINICAL NEUROPHARMACOLOGY
    75. Kalsner, S
      The question of feedback at the somadendritic region and antidepressant drug action

      BRAIN RESEARCH BULLETIN
    76. Bendtsen, L
      Central sensitization in tension-type headache - possible pathophysiological mechanisms

      CEPHALALGIA
    77. Venkatakrishnan, K; von Moltke, LL; Greenblatt, DJ
      Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance

      CLINICAL PHARMACOKINETICS
    78. Schlosser, R; Wetzel, H; Dorr, H; Rossbach, W; Hiemke, C; Benkert, O
      Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers

      PSYCHONEUROENDOCRINOLOGY
    79. Oberndorfer, S; Saletu-Zyhlarz, G; Saletu, B
      Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality

      NEUROPSYCHOBIOLOGY
    80. Nolen, WA; Bleomkolk, D
      Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm

      NEUROPSYCHOBIOLOGY
    81. Van der Linden, G; Van Heerden, B; Warwick, J; Wessels, C; Van Kradenburg, J; Zungu-Dirwayi, N; Stein, DJ
      Functional brain imaging and pharmacotherapy in social phobia: Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    82. Nolting, A; Abramowitz, W
      Lack of interaction between citalopram and the CYP3A4 substrate triazolam

      PHARMACOTHERAPY
    83. von Moltke, LL; Greenblatt, DJ
      Drug transporters in psychopharmacology - Are they important?

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    84. Hassan, PC; Sproule, BA; Naranjo, CA; Herrmann, N
      Dose-response evaluation of the interaction between sertraline and alprazolam in vivo

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    85. Millan, MJ; Lejeune, F; Gobert, A
      Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

      JOURNAL OF PSYCHOPHARMACOLOGY
    86. Hjorth, S; Bengtsson, HJ; Kullberg, A; Carlzon, D; Peilot, H; Auerbach, SB
      Serotonin autoreceptor function and antidepressant drug action

      JOURNAL OF PSYCHOPHARMACOLOGY
    87. Hidalgo, RB; Davidson, JRT
      Selective serotonin reuptake inhibitors in post-traumatic stress disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    88. El-Giamal, N; de Zwaan, M; Bailer, U; Lennkh, C; Schussler, P; Strnad, A; Kasper, S
      Reboxetine in the treatment of bulimia nervosa: a report of seven cases

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    89. Berk, M; Stein, DJ; Potgieter, A; Maud, CM; Els, C; Janet, ML; Viljoen, E
      Serotonergic targets in the treatment of antidepressant induced sexual dysfunction: a pilot study of granisetron and sumatriptan

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    90. Stein, DJ; Stahl, S
      Serotonin and anxiety: current models

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    91. Shelton, RC
      Cellular mechanisms in the vulnerability to depression and response to antidepressants

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    92. Sorensen, E; Bjorvatn, B; Ursin, R
      Sleep-wake effects following the selective 5-HT1A receptor antagonist p-MPPI in the freely moving rat

      BEHAVIOURAL BRAIN RESEARCH
    93. Gelenberg, AJ; Laukes, C; McGahuey, C; Okayli, G; Moreno, F; Zentner, L; Delgado, P
      Mirtazapine substitution in SSRI-induced sexual dysfunction

      JOURNAL OF CLINICAL PSYCHIATRY
    94. Moller, SE; Larsen, F; Pitsiu, M; Rolan, PE
      Effect of citalopram on plasma levels of oral theophylline

      CLINICAL THERAPEUTICS
    95. Kashyap, AS
      Phaeochromocytoma unearthed by fluoxetine

      POSTGRADUATE MEDICAL JOURNAL
    96. Yoo, HS; Bunnell, BN; Crabbe, JB; Kalish, LR; Dishman, RK
      Failure of neonatal clomipramine treatment to alter forced swim immobility: chronic treadmill or activity-wheel running and imipramine

      PHYSIOLOGY & BEHAVIOR
    97. Bristow, LJ; O'Connor, D; Watts, R; Duxon, MS; Hutson, PH
      Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

      NEUROPHARMACOLOGY
    98. Stenfors, C; Yu, H; Ross, SB
      Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain

      NEUROPHARMACOLOGY
    99. Lucas, G; De Deurwaerdere, P; Porras, G; Spampinato, U
      Endogenous serotonin enhances the release of dopamine in the striatum onlywhen nigro-striatal dopaminergic transmission is activated

      NEUROPHARMACOLOGY
    100. Dreshfield-Ahmad, LJ; Thompson, DC; Schaus, JM; Wong, DT
      Enhancement in extracelllar serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine

      LIFE SCIENCES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 21:29:09